TrialCancer2009

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium.

Deborah Bradley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.